Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders

NEXT STORY
TG Therapeutics Presents Positive Interim Data from UNITY-NHL Phase 2b Trial Evaluating Umbralisib Monotherapy in Patients with Marginal Zone Lymphoma at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting
PREV STORY
XBiotech Announces Closing of Public Offering of Common Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics and Massachusetts General Hospital Enter Memorandum Of Understanding to Develop Point-of-Care Fever Diagnostic Test

MEDFORD, N.Y., May 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...

author_avatar
NASDAQ Market News

BeyondSpring Announces Positive Topline Results from its PROTECTIVE-2 Phase 3 Registrational Trial of Plinabulin in Combination with Pegfilgrastim for Prevention of Chemotherapy-Induced Neutropenia

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Oy’s Board of Directors has decided on the directed share issue without payment to the Company itself

FIT Biotech OyCompany release March 9, 2018 at 2.00 pm EET FIT Biotech Oy's ...

author_avatar
NASDAQ Market News